Allecra Therapeutics, founded in 2013, is a private, clinical-stage biopharmaceutical company developing novel therapies to combat antibiotic resistance by overcoming emergent resistance mechanisms. Lead product candidate, cefepime/enmetazobactam, has shown superiority over standard of care in patients with complicated urinary tract infections (cUTIs) in a randomized, controlled, double-blind, global Phase 3 trial, and the Company is preparing submissions for marketing approval in the U.S. and EU based on these results. The Company has significant patent protection covering proprietary enmetazobactam in major territories. Allecra’s investors are: Forbion, Andera Partners, Delos Capital, Xeraya Capital, EMBL Ventures, and BioMedPartners. Allecra’s wholly owned French subsidiary is a beneficiary of financial support from Bpifrance and the Région Alsace.
View Top Employees from Allecra TherapeuticsWebsite | http://www.allecra.com |
Revenue | $5 million |
Funding | $44.4 million |
Employees | 7 (5 on RocketReach) |
Founded | 2013 |
Address | 10 Rue Alexandre Freund, St. Louis, Grand Est 68300, FR |
Phone | +33 3 89 68 98 76 |
Technologies |
JavaScript,
HTML,
PHP
+11 more
(view full list)
|
Industry | Biotechnology Research, Business Services General, Biopharma, Business Services, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
Web Rank | 15 Million |
Keywords | Allecra Therapeutics, Cefepime/Aai101, Lanicia Williams Allecra Therapeutics, Allecra Therapeutica Company, Allecra In The U.S. |
Competitors | Nabriva Therapeutics plc, Sequella, Inc., Spero Therapeutics, Spruce Biosciences, Tetraphase Pharmaceuticals |
SIC | SIC Code 873 Companies, SIC Code 87 Companies |
NAICS | NAICS Code 541713 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies |
Looking for a particular Allecra Therapeutics employee's phone or email?
The Allecra Therapeutics annual revenue was $5 million in 2023.
Velicitat Patrick is the Chief Medical Officer of Allecra Therapeutics.
5 people are employed at Allecra Therapeutics.
Allecra Therapeutics is based in St. Louis, Grand Est.
The NAICS codes for Allecra Therapeutics are [541713, 5417, 54171, 54, 541].
The SIC codes for Allecra Therapeutics are [873, 87].